Neurology Minute

In part two of this two-part series, Dr. Dan Ackerman and Dr. Trey Bateman discuss handling patient requests for blood-based biomarkers for Alzheimer disease and interpreting test results.

Dr. Jessica Ailani and Dr. Kathleen Digre discuss the evolution of spontaneous intracranial hypotension (SIH) diagnosis and treatment over the past decade.

In part one of this two-part series, Dr. Dan Ackerman and Dr. Trey Bateman discuss current biomarkers for Alzheimer disease and how do you use them in clinic.

Dr. Justin Abbatemarco discusses updates around MOGAD treatments. Show references: https://jamanetwork.com/journals/jamaneurology/article-abstract/2822964 https://jnnp.bmj.com/content/95/11/1054

Dr. Justin Abbatemarco discusses autoimmune encephalitis with a focus on outcomes. Show references: https://www.neurology.org/doi/10.1212/WNL.0000000000210109 https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00463-5/abstract

Dr. Halley Alexander discusses the Neurology Today article, "The AAN Updates Its Position Statement on Seizures, Driver Licensure, and Medical Reporting," by Gina Shaw, available in the latest issue of Neurology Today or at neurologytoday.com. Show reference: The AAN Updates Its Position Statement on Seizures, Driver Licensure, and Medical Reporting

Dr. Greg Cooper and Dr. Joseph Therriault discuss the use of plasma biomarkers in diagnosing Alzheimer disease. Show reference: https://doi.org/10.1038/s43587-024-00731-y

Dr. Halley Alexander and Dr. Paula Marques discuss sex differences in genetically determined epilepsies. Show reference: https://www.neurology.org/doi/10.1212/NXG.0000000000200233

Dr. Justin Abbatemarco discusses updates around treatments in AQP4+ NMOSD. Show references: https://pubmed.ncbi.nlm.nih.gov/38760098/ https://www.neurology.org/doi/10.1212/NXI.0000000000200071

In the final part of this three-part series, Dr. Justin Abbatemarco and Dr. Jiwon Oh discuss how to address questions related to BTK Inhibitors with patients. Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2415985 https://www.nejm.org/doi/full/10.1056/NEJMoa2415988

In part two of this three-part series, Dr. Justin Abbatemarco and Dr. Jiwon Oh discuss the clinical trial data available in both the relapsing and progressive cohorts. Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2415985 https://www.nejm.org/doi/full/10.1056/NEJMoa2415988

In part one of this three-part series, Dr. Justin Abbatemarco and Dr. Jiwon Oh discuss how Bruton Tyrosine Kinase (BTK) Inhibitors work and how they vary from other disease-modifying therapies. Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2415985 https://www.nejm.org/doi/full/10.1056/NEJMoa2415988

Dr. Justin Abbatemarco provides an update on autologous hematopoietic stem cell transplantation in multiple sclerosis. Show reference: https://www.nature.com/articles/s41582-024-01050-x

In this women's history minute, Dr. Alison Christy discusses the life and legacy of Mary A. B. Brazier.

In part two of this two-part series, Dr. Jeff Ratliff and Dr. Harry Sutherland discuss the diverse strategies that residency programs implement to ensure residents can continue their education in a protected and supportive environment. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200205

In part one of this two-part series, Dr. Jeff Ratliff and Dr. Harry Sutherland discuss how neurology residency programs are incorporating didactic teaching methods to enhance learning outside the clinical environment. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200205

Dr. Jessica Ailani and Dr. Richard B. Lipton discuss the significance of recognizing prodromal symptoms, the findings from the PRODROME trial, and the implications for clinical practice. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200359

Dr. Tesha Monteith discusses an abstract that was presented at the AAN Annual Meeting titled, "Estrogen Exposure from Modern Hormonal Contraceptives and Vascular Risk in Women with Migraine: A Nationwide Electronic Health Record Database Study." Show reference: https://index.mirasmart.com/AAN2025/PDFfiles/AAN2025-002306.html

In the final episode of this four-part series, Dr. Justin Abbatemarco and Dr. Nancy Newman discuss the abstract she presented at the AAN Annual Meeting and details on the upcoming gene therapy trial. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000208987

Prof. Jon Stone, Dr. Laura Strom, and Meagan Watson discuss functional seizures and healthcare costs related to the functional seizure program at the University of Colorado. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200393

Neurology® Open Access has officially launched! In part two of this two-part series, Dr. Jeff Ratliff and Dr. Amy C. Kunchok discuss the advantages of an open-access publication model. Read the related editorial in Neurology® Open Access.

Neurology® Open Access has officially launched! In part one of this two-part series, Dr. Jeff Ratliff and Dr. Amy C. Kunchok discuss the scope and focus of Neurology® Open Access (NOA). Read the related editorial in Neurology® Open Access.

In part two of this four-part series, Dr. Justin Abbatemarco and Dr. Nancy Newman discuss current treatment options for Leber hereditary optic neuropathy (LHON). Show reference: https://index.mirasmart.com/AAN2025/PDFfiles/AAN2025-002206.html

In part two of this four-part series, Dr. Justin Abbatemarco and Dr. Nancy Newman discuss current treatment options for Leber hereditary optic neuropathy (LHON). Show reference: https://index.mirasmart.com/AAN2025/PDFfiles/AAN2025-002206.html

In part two of this two-part series, Dr. Jeff Ratliff and Dr. Mehari Gebreyohanns discuss the essence of humanistic care.

In part one of this two-part series, Dr. Jeff Ratliff and Dr. Mehari Gebreyohanns discuss the Bahir Dar Outreach for Neurology Education (BORNE) initiative.

Dr. Gordon Smith and Dr. Jennifer Morganroth discuss the trends in thymectomy utilization for myasthenia gravis. References: https://www.neurology.org/doi/10.1212/CPJ.0000000000200335

In part one of this four-part series, Dr. Justin Abbatemarco and Dr. Nancy Newman discuss how Leber hereditary optic neuropathy (LHON) typically presents and outline the steps for diagnosing LHON in a clinical setting. Show reference: https://index.mirasmart.com/AAN2025/PDFfiles/AAN2025-002206.html

Dr. Joyce K. Lee-Iannotti introduces the collaborative section showcase happening in-person at the 77th AAN Annual Meeting on Monday, April 7th, from 12:00 - 1:00 pm PDT in room 24AB. Experts from the sleep, headache, and concussion sections are coming together to host a pro/con debate on pressing issues affecting the field of neurology. Click here to learn more about the AAN Section Showcase: Busting Myths in Sleep, Headache, and Concussion: Pro/Con Debate.

In the fourth and final episode of this four-part series, Dr. Justin Abbatemarco and Dr. Albert Aboseif discuss treatment options currently available for patients with LGI-1-AE. Show reference: https://index.mirasmart.com/AAN2025/PDFfiles/AAN2025-003990.html

Dr. Andrea Gropman and Dr. Stefan Pulst discuss the significant advancements in Neurology® Genetics over the past decade. Show reference: https://www.neurology.org/doi/10.1212/NXG.0000000000200252

Dr. Jessica Ailani and Dr. Francesca Puledda discuss the International Headache Society's global practice recommendations for acute and preventive treatment of migraine. Show reference: https://journals.sagepub.com/doi/10.1177/03331024241252666 https://journals.sagepub.com/doi/full/10.1177/03331024241269735

In the third episode of this four-part series, Dr. Justin Abbatemarco and Dr. Albert Aboseif discuss the inspiration behind this abstract. Show reference: https://index.mirasmart.com/AAN2025/PDFfiles/AAN2025-003990.html

In the second part of this four-part series, Dr. Justin Abbatemarco and Dr. Albert Aboseif discuss treatment options for LGI-1 encephalitis. Show reference: https://index.mirasmart.com/AAN2025/PDFfiles/AAN2025-003990.html

In part one of this four-part series, Dr. Justin Abbatemarco and Dr. Albert Aboseif discuss how LGI-1 encephalitis typically presents in clinic and how to make the correct diagnosis. Show reference: https://index.mirasmart.com/AAN2025/PDFfiles/AAN2025-003990.html

Dr. Dan Ackerman and Dr. Phillip Ferdinand discuss the impact smoking has on stroke risk. Show reference: https://www.neurology.org/doi/10.1212/WN9.0000000000000003

Dr. Gordon Smith and Dr. Timothy Miller discuss compelling clinical data suggesting that ALS may be a treatable disease for a subset of patients.

In the final part of this three-part series, Dr. Jason Crowell delves into the third issue discussed at NOH, funding for NINDS and the BRAIN Initiative. Show reference: https://www.aan.com/advocacy/

In the second part of this three-part series, Dr. Jason Crowell delves into the second issue discussed at NOH, emphasizing the importance of extending telehealth flexibilities. Show reference: https://www.aan.com/advocacy/

In the first installment of this three-part series, Dr. Jason Crowell discusses the impact cuts to the Medicare Fee Scheduler has on patient care and the field of neurology. Show reference: https://www.aan.com/advocacy/

Dr. Trey Bateman and Dr. Amy Brodtmann discuss referrals for frontal network impairment and FTD, highlighting the most helpful information for reaching a final diagnosis after evaluation. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200360

Dr. Tesha Monteith and Dr. Patricia Pozo-Rosich discuss the latest advancements in headache medicine, focusing on key research findings from 2024.

Dr. Tesha Monteith and Dr. Patricia Pozo-Rosich discuss the latest advancements in headache medicine, focusing on key research findings from 2024.

Dr. Alberto Ramos discusses the importance of sleep for brain health.

Dr. Alberto Ramos discusses how managing risk factors for sleep apnea can significantly reduce systemic vascular risks and preserve neurologic function.

Dr. Tesha Monteith discusses the Headache Journal article, "Association of Migraine Treatments with Reduced Ischemic Stroke Risk: Evidence from Two Large-Scale Real-World Data Analyses." Show reference: https://headachejournal.onlinelibrary.wiley.com/doi/10.1111/head.14918

Dr. Alison Christy and Dr. Wallace J. Brownlee discuss whether dissemination in time is necessary to make a diagnosis of MS in patients who fulfill a high number of dissemination in space criteria. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000210274

In part two of this two-part series, Dr. Andy Southerland and Dr. Seemant Chaturvedi discuss the PRESTIAGE-AF trial. Show references: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00333-2/fulltext

In part one of this two-part series, Dr. Andy Southerland and Dr. Seemant Chaturvedi discuss two trials that were looking at the use of endovascular therapy for medium vessel occlusion. Show references: https://www.nejm.org/doi/full/10.1056/NEJMoa2411668 https://www.nejm.org/doi/full/10.1056/NEJMoa2408954

Dr. Jeff Ratliff delves into the common causes of acquired dystonia and highlights evidence-based treatment strategies for effective management.